| May 24, 2013 |
An anti-cancer drug may reverse memory problems in an Alzheimer's Disease mouse model, according to new research carried out at the University of Pittsburgh Graduate School of Public Health. The study, published in the journal Science, examined previously published outcomes on the drug bexarotene - which is approved by the U.S... Read More
|
| May 24, 2013 |
Netherlands first to approve new fixed-dose combination treatment for men with lower urinary tract symptoms associated with BPH ASTELLAS PHARMA EUROPE B.V., the European subsidiary of Tokyo-based Astellas Pharma Inc.(Tokyo:4503), have announced the Dutch Medicines Evaluation Board (MEB) has granted marketing authorisation for VESOMNI in the Netherlands... Read More
|
| May 24, 2013 |
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH)... Read More
|
| May 24, 2013 |
Scientists at the University of East Anglia (UEA) have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function... Read More
|
| May 23, 2013 |
Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published in the /iJournal of the American Chemical Society... Read More
|
| May 23, 2013 |
When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness. But repeated infections and inflammation can deplete these cell populations, potentially leading to the development of serious blood conditions such as cancer... Read More
|
| May 23, 2013 |
Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop. Now, researchers at the University of Missouri have found a way to create radioactive nanoparticles that target lymphoma tumor cells wherever they may be in the body... Read More
|
| May 23, 2013 |
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report... Read More
|
| May 23, 2013 |
Results from a large observational study reported at EuroPCR 2013 question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)... Read More
|
| May 23, 2013 |
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer... Read More
|
|
Next Page
|
